ascorbic-acid and Uterine-Hemorrhage

ascorbic-acid has been researched along with Uterine-Hemorrhage* in 7 studies

Other Studies

7 other study(ies) available for ascorbic-acid and Uterine-Hemorrhage

ArticleYear
IUD induced bleeding and the way of therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1984, Volume: 22, Issue:3

    In a retrospective study containing 2404 cases of IUD induced bleeding problems, the type and timing of bleeding as well as the types of conservative therapy were evaluated. The non-hormonal treatment (uterotonics, calcium, C- and K-vitamin etc.) proved to be significantly less effective (P less than 0.05) than the hormonal therapy (estrogen, gestagen and combined preparations). The rate of effectiveness was 80.1% and 86.7%, respectively. Because the effectiveness of the conservative therapy is 80%, even in the non-hormonal group, the IUD should be removed only if this treatment proves to be ineffective. Attention is drawn to the importance of routine colposcopic and cytological screening.

    Topics: Ascorbic Acid; Calcium; Estrenes; Ethinyl Estradiol; Ethisterone; Female; Histamine H1 Antagonists; Humans; Intrauterine Devices; Lynestrenol; Norethindrone; Retrospective Studies; Uterine Hemorrhage; Vitamin K

1984
[Certain problems of histochemistry of the endometrium in dysfunctional uterine hemorrhages of the climacteric period].
    Akusherstvo i ginekologiia, 1975, Issue:3

    Topics: Adult; Ascorbic Acid; Dihydrolipoamide Dehydrogenase; Endometrium; Female; Glycogen; Glycosaminoglycans; Histocytochemistry; Humans; Menopause; Middle Aged; Monoamine Oxidase; Succinate Dehydrogenase; Uterine Hemorrhage

1975
[Treatment of haemorrhage during insertion of IUD].
    Ceskoslovenska gynekologie, 1975, Volume: 40, Issue:2

    It was ascertained and confirmed statistically in 96 women that Lysenyl shortens the period of hemorrhage after insertion of an IUD; depot Agofollin, Lysenyl, and in particular Ascorutin reduce the intensity of hemorrhage. In women with hemorrhage in the middle and 2nd half of the cycle, with the IUD in situ, a combination of Lysenyl and Ascorutin proved most useful. More severe cases were treated with Norethisterone. It was recommended in more severe cases to treat, in addition to the above preparations, with hormones - in the 1st half of the cycle with estrogens and in the 2nd half with norsteroids.

    Topics: Amines; Ascorbic Acid; Ergolines; Ergot Alkaloids; Female; Humans; Intrauterine Devices; Maleates; Rutin; Uterine Hemorrhage

1975
[Acute hemorrhage from the female genitals].
    Zeitschrift fur arztliche Fortbildung, 1975, Apr-15, Volume: 69, Issue:8

    Topics: Abortion, Spontaneous; Aminocaproates; Ascorbic Acid; Extraembryonic Membranes; Female; Genitalia, Female; Humans; Labor, Obstetric; Oxytocin; Placenta Previa; Pregnancy; Pyridoxine; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Rupture; Vitamin K

1975
[Ascorbic acid content in the blood and urine of women suffering menopausal hemorrhages].
    Voprosy onkologii, 1969, Volume: 15, Issue:7

    Topics: Ascorbic Acid; Female; Humans; Menopause; Neoplasms; Uterine Hemorrhage

1969
A treatment for excessive uterine bleeding.
    Applied therapeutics, 1961, Volume: 3

    Topics: Ascorbic Acid; Female; Flavonoids; Humans; Menorrhagia; Metrorrhagia; Uterine Hemorrhage

1961
[Experiences with large doses vitamin C therapy in functional uterine hemorrhage].
    Magyar noorvosok lapja, 1951, Volume: 14, Issue:8

    Topics: Ascorbic Acid; Female; Humans; Uterine Hemorrhage; Uterus; Vitamins

1951